Skip to main content
AkademIndex

Products

For developers

AkademBaseOpen API for the ecosystem
← Back to work

Works cited by this work

32 works

Work: Effectiveness and Safety of a Shorter Treatment Regimen in a Setting with a High Burden of Multidrug-Resistant Tuberculosis

  1. Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011

    Dilrabo Ulmasova, G Uzakova, M N Tillyashayhov +17

    ArticleTuberculosis Research and EpidemiologyEurosurveillance201315 citations
    ABI

  2. Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis

    Armand Van Deun, Aung Kya Jai Maug, Md Abdul Hamid Salim +4

    Article201011 citations
    ABI

  3. A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis

    Andrew Nunn, Patrick Phillips, Sarah Meredith +16

    Article20196 citations
    ABI

  4. Treatment outcome with a short multidrug-resistant tuberculosis regimen in nine African countries

    Arnaud Trébucq, V Schwoebel, Zacharie Kashongwe +15

    Article20176 citations
    ABI

  5. Successful ‘9-month Bangladesh regimen’ for multidrug-resistant tuberculosis among over 500 consecutive patients

    K. J. M. Aung, Armand Van Deun, Erik De Clercq +4

    Article20145 citations
    ABI

  6. Reasons for defaulting from drug-resistant tuberculosis treatment in Armenia: a quantitative and qualitative study

    Elisabeth Sánchez-Padilla, Caroline Marquer, Stobdan Kalon +5

    Article20145 citations
    ABI

  7. Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses

    Faiz Ahmad Khan, M Salim, Philipp du Cros +9

    Review articleTuberculosis Research and EpidemiologyEuropean Respiratory Journal20174 citations
    ABI

  8. “When Treatment Is More Challenging than the Disease”: A Qualitative Study of MDR-TB Patient Retention

    Kalpita Shringarpure, Petros Isaakidis, Karuna D. Sagili +3

    Article20163 citations
    ABI

  9. What is new in the WHO consolidated guidelines on drug-resistant tuberculosis treatment?

    Surendra K. Sharma, Keertan Dheda

    Editorial20193 citations
    ABI

  10. Drug-resistant tuberculosis in eastern Europe and central Asia: a time-series analysis of routine surveillance data

    Andrei Dadu, Arax Hovhannesyan, Sevim Ahmedov +2

    Article20192 citations
    ABI

  11. Applicability of the shorter ‘Bangladesh regimen’ in high multidrug-resistant tuberculosis settings

    Giovanni Sotgiu, Simon Tiberi, Rosella Centis +4

    Article20162 citations
    ABI

  12. RAWGraphs

    Michele Mauri, Tommaso Elli, Giorgio Caviglia +2

    Article20172 citations
    ABI

  13. Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

    S.K. Abidi, Jay Achar, M.M. Assao Neino +34

    ArticleTuberculosis Research and EpidemiologyEuropean Respiratory Journal20191 citations
    ABI

  14. Untitled

    Other1 citations
    ABI

  15. Untitled

    Other1 citations
    ABI

  16. Untitled

    Other1 citations
    ABI

  17. Untitled

    Other1 citations
    ABI

  18. Untitled

    Other1 citations
    ABI

  19. Untitled

    Other1 citations
    ABI

  20. Untitled

    Other1 citations
    ABI

  21. Untitled

    Other1 citations
    ABI

  22. Untitled

    Other1 citations
    ABI

  23. Untitled

    Other1 citations
    ABI

  24. Untitled

    Other1 citations
    ABI

  25. Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan

    Philipp du Cros, Atadjan Khamraev, Zinaida Tigay +15

    ArticleTuberculosis Research and EpidemiologyERJ Open Research20201 citations
    ABI